Li, L., Li, L., Huang, Q., Sun, J., Yan, F., Wei, W., … Deng, J. (2022). Efficacy and safety of osimertinib for patients with EGFR-mutated NSCLC: a systematic review and meta-analysis of randomized controlled studies. Acta Oncologica, 61(11), 1347–1353. https://doi.org/10.1080/0284186X.2022.2132116